Mary M Hitt (Mary Hitt)

Years Active: 2019-2023
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Quinn T Storozynsky, Xuefei Han, Shae Komant, Kate C Agopsowicz, Kyle G Potts, Armin M Gamper, Roseline Godbout, David Hugh Evans, Mary M Hitt
Radiation-Induced Cellular Senescence Reduces Susceptibility of Glioblastoma Cells to Oncolytic Vaccinia Virus. Cancers 15 (13) (2023)
Quinn Storozynsky, Mary M Hitt
The Impact of Radiation-Induced DNA Damage on cGAS-STING-Mediated Immune Responses to Cancer. International journal of molecular sciences 21 (22) (2020)
Brittany A Umer, Ryan S Noyce, Brian C Franczak, Mira M Shenouda, Rees G Kelly, Nicole A Favis, Megan Desaulniers, Troy A Baldwin, Mary M Hitt, David H Evans
Deciphering the Immunomodulatory Capacity of Oncolytic Vaccinia Virus to Enhance the Immune Response to Breast Cancer. Cancer immunology research 8 (5) (2020)
Aravindhan Ganesan, Marawan Ahmed, Isobel Okoye, Elena Arutyunova, Dinesh Babu, William L Turnbull, Joydeb Kumar Kundu, Justin Shields, Katharine Cheryl Agopsowicz, Lai Xu, Yasser Tabana, Nutan Srivastava, Guangzhi Zhang, Tae Chul Moon, Alexandr Belovodskiy, Mostofa Hena, Appan Srinivas Kandadai, Seyedeh Nargess Hosseini, Mary M Hitt, John Walker, Michael Smylie, Frederick G West, Arno G Siraki, M Joanne Lemieux, Shokrollah Elahi, James A Nieman, D Lorne Tyrrell, Michael Houghton, Khaled Barakat
Comprehensive in vitro characterization of PD-L1 small molecule inhibitors. Scientific reports 9 (1) (2019)

Mary M Hitt.css-eqlu8i{font-size:small;padding-left:4px;} (Mary Hitt)